Gene therapy for CNGB3-associated achromatopsia
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gene therapy for CNGB3-associated achromatopsia, covering 2023-03-08 to 2023-03-08. Get the full timeline:
Most recent: Clinical Trial Update: Gene Therapy for Achromatopsia (CNGB3) [Phase 1, Phase 2]